InsiderClue
← All stocks

Coherus Oncology, Inc.

CHRS Net selling
CIK 0001512762 #3931 in the set updated 22 Sep 2026
Bought (120 mo)
$49.67K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$66.47M
$0.00 on a plan · $11.67M straight out of an exercise
Sold at will
$54.81M
44 of 107 sales
Net
−$66.43M
−$54.76M against sales at will

By person

21 insiders · 117 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
HEALY JAMES
Director
—
$27.90M (8)
−$27.90M
504,641
0.3266%
$372.88K
−84.8%
Lanfear Dennis M
President & CEO
—
$16.93M (6)
−$16.93M
2,014,568
1.30%
$1.49M
+3.7%
Wahlstrom Mats
Director
—
$7.35M (6)
−$7.35M
30,000
0.0194%
$22.17K
−95.3%
Anicetti Vincent R
Chief Operating Officer
—
$4.44M (33) scheduled
−$4.44M
124,790
0.0808%
$92.21K
+992.3%
Vexler Vladimir
Chief Scientific Officer
—
$3.08M (3) scheduled
−$3.08M
116,361
0.0753%
$85.98K
+716.3%
Viret Jean-Frederic
Chief Financial Officer
—
$2.85M (29) scheduled
−$2.85M
61,295
0.0397%
$45.29K
+507.8%
Herman Alan C.
Chief Scientific Officer
—
$2.78M (15)
−$2.78M
350,624
0.2269%
$259.08K
−25.4%
Szela Mary T
Director
—
$966.76K (1) scheduled
−$966.76K
0
0.0000%
$0.00
—
FINCK BARBARA K
Chief Medical Officer
—
$118.99K (5) scheduled
−$118.99K
37,043
0.0240%
$27.37K
+25.6%
Stilwell McDavid
Chief Financial Officer
$49.67K (1)
$58.92K (1)
−$9.25K
75,305
0.0487%
$55.64K
+1,175%
Troendle August J.
Director
—
—
—
298,422
0.1932%
$220.50K
0.0%
McMichael Bryan J
Chief Financial Officer
—
—
—
133,736
0.0866%
$98.82K
+604.4%
Reider Paul
Chief Commercial Officer
—
—
—
82,069
0.0531%
$60.64K
−20.2%
Richards Christos
Director
—
—
—
63,836
0.0413%
$47.17K
0.0%
Satvat Ali J.
Director
—
—
—
30,000
0.0194%
$22.17K
—
Newton Charles W.
Director
—
—
—
30,000
0.0194%
$22.17K
—
Newcomer Lee Nisley
Director
—
—
—
30,000
0.0194%
$22.17K
—
Karachun Rita A
Director
—
—
—
30,000
0.0194%
$22.17K
—
Ryan Michael Lee
Director
—
—
—
30,000
0.0194%
$22.17K
—
O'Donnell-Tormey Jill
Director
—
—
—
30,000
0.0194%
$22.17K
—
Watler Peter K.
Chief Technical Officer
—
—
—
5,900
0.0038%
$4.36K
—

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Wahlstrom Mats
1 Feb 2024
Director
Exercised, kept
44,991
$1.67
$75.00K
Wahlstrom Mats
1 Feb 2024
Director
Exercised, kept
14,997
$1.67
$25.00K
Lanfear Dennis M
6 Jun 2021
President & CEO
Exercised, kept
300,000
$0.42
$125.04K
Lanfear Dennis M
1 Jul 2020
President & CEO
Exercised, kept
29,994
$0.01
$248.95
HEALY JAMES
12 Jan 2020
Director
Exercised, kept
20,000
$12.37
$247.40K
HEALY JAMES
9 Jan 2020
Director
Exercised, kept
20,000
$10.05
$201.00K
HEALY JAMES
9 Jan 2020
Director
Exercised, kept
29,994
$1.67
$50.00K
Viret Jean-Frederic
21 Sep 2018
Chief Financial Officer
Exercised, kept
740
$13.50
$9.99K
Viret Jean-Frederic
19 Dec 2016
Chief Financial Officer
Exercised, kept
667
$13.50
$9.00K
Show all 117 transactions →

What was left out

Form 4 filings counted 263
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 63
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 6,673,645
Sales filed before the plan box existed 43
History held since 6 Sep 2016